In this context, endocan could be a promising biomarker for the early diagnosis and prognosis of chronic inflammatory states in T2DM and periodontal disease, due to its ability to reflect the impact of endothelial activation in these pathological conditions. Here, ESM1 is linked to periodontal disorder.